Annual progress reports
All eligible countries are invited to submit proposals for Gavi support.
Annual progress report India 2001
Annual progress report India 2014
Annual progress report India 2013
Annual progress report India 2012
Annual progress report India 2011
Annual progress report India 2010
Annual progress report India 2009
Annual progress report India 2008
Annual progress report India 2007
Annual progress report India 2006
Annual progress report India 2005
Annual progress report India 2004
Annual progress report India 2003
Annual progress report India 2002
Proposal for HSS support 2017: India
Proposal for NVS rota support 2017 - India
Proposal for NVS - MR support 2017: India
Proposal for NVS - MR - PCV support 2017: India
Proposal for NVS - PCV support 2017: India
Proposal for NVS - IPV support: India
Proposal for Penta Scale up support: India
Proposal for HSS: India
Proposal for NVS - Hib support: India
Proposal for NVS - Hep B support: India
Proposal for INS support: India
Proposal for NVS - Hep B extension support: India
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet India
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter HSS India 2021
Decision Letter PCV India 2021
Decision Letter PCV India 2020
Decision Letter NVS India 2015 (2)
Decision Letter NVS India 2015
Decision Letter NVS India 2014(2)
Decision Letter HSS India 2014
India Decision letter HSS 2019
Decision Letter NVS India 2014
Decision Letter NVS India 2018 (2)
Decision letter NVS India 2013
Decision Letter NVS India 2018 (3)
Decision letter HSS India 2013
Decision Letter NVS India 2018
Decision Letter NVS India 2017 (2)
Decision Letter NVS India 2017
Decision Letter HSS India 2017
Decision Letter NVS India 2016 (5)
Decision Letter NVS India 2016 (4)
Decision Letter NVS India 2016 (3)
Decision Letter NVS India 2016 (2)
Decision Letter NVS India 2016
Decision Letter HSS India 2016
Decision Letter PCV India 2019
Decision Letter IPV India 2019
COVAX Technical Assistance Plans
In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.
COVAX Technical Assistance Plan India 2021
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.